Consumer Reports comes out with their recommendations on calcium channel blockers
Note that CCBs are not first-line medications for hypertension. Also note that Pfizer’s Norvasc, the world’s best-selling antihypertensive, is nowhere to be found in the recommendations.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
